RJA
DBD

Raymond James & Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

Raymond James & Associates’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,312
Closed -$103K – 4273
2022
Q1 		$103K Buy
+15,312
New +$131K ﹤0.01% 3817
2018
Q3 		– Sell
-413,977
Closed -$4.95M – 3741
2018
Q2 		$4.95M Buy
413,977
+32,994
+9% +$442K 0.01% 1194
2018
Q1 		$5.87M Buy
380,983
+42,360
+13% +$707K 0.01% 1056
2017
Q4 		$5.54M Sell
338,623
-11,491
-3% -$222K 0.01% 1061
2017
Q3 		$8M Buy
350,114
+240,813
+220% +$5.13M 0.02% 856
2017
Q2 		$3.06M Buy
109,301
+16,203
+17% +$448K 0.01% 1300
2017
Q1 		$2.86M Buy
93,098
+22,794
+32% +$644K 0.01% 1328
2016
Q4 		$1.77M Sell
70,304
-6,359
-8% -$150K ﹤0.01% 1564
2016
Q3 		$1.9M Buy
76,663
+13,258
+21% +$352K 0.01% 1486
2016
Q2 		$1.57M Sell
63,405
-1,865
-3% -$48K ﹤0.01% 1468
2016
Q1 		$1.89M Sell
65,270
-7,446
-10% -$195K 0.01% 1305
2015
Q4 		$2.19M Buy
72,716
+7,799
+12% +$265K 0.01% 1217
2015
Q3 		$1.93M Buy
64,917
+9,136
+16% +$297K 0.01% 1236
2015
Q2 		$1.95M Sell
55,781
-8,751
-14% -$309K 0.01% 1335
2015
Q1 		$2.29M Sell
64,532
-3,783
-6% -$127K 0.01% 1166
2014
Q4 		$2.37M Sell
68,315
-23,166
-25% -$817K 0.01% 1065
2014
Q3 		$3.23M Buy
91,481
+16,077
+21% +$607K 0.02% 838
2014
Q2 		$3.03M Buy
75,404
+12,137
+19% +$466K 0.02% 872
2014
Q1 		$2.52M Buy
63,267
+10,458
+20% +$376K 0.02% 896
2013
Q4 		$1.74M Buy
52,809
+16,646
+46% +$519K 0.01% 1039
2013
Q3 		$1.06M Buy
36,163
+3,532
+11% +$111K 0.01% 1228
2013
Q2 		$1.1M Buy
+32,631
New +$1.01M 0.01% 1126

Other funds holding DBD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Raymond James & Associates's DBD Position: Q2 2022 in Review

Raymond James & Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 15,312 shares — an estimated $103K sold.

Raymond James & Associates first reported a position in DBD in Q2 2013 and held it in 22 quarters. The position peaked at $8M in Q3 2017. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Raymond James & Associates reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 15,312 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $103K.
  • Raymond James & Associates first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 22 quarters.
  • Raymond James & Associates's Diebold Nixdorf Incorporated position peaked at $8M in Q3 2017.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.